REC-200

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameREC-200
Drug Alias Nameliposomal glucocorticoidPEGylated nanoliposome encapsulated glucocorticoid (Recoly)REC-200
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor inhibitors
TargetsGlucocorticoid receptor
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecoly Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecoly Nv
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A